 Amid a strong showing on Wall Street prior to the weekend, shares of CureVac NASDAQ: CVAC stock popped dramatically northward on positive data for its coronavirus and flu vaccines. Preliminary clinical results demonstrate effectiveness against the omicron variant of Covid-19 along with the seasonal flu. 